Recherche
Voici les éléments 1-5 de 5
Chroniques génomiques - Le Graal de Grail est-il un mirage ?
(Éditions EDK, Groupe EDP Sciences, 2016)
A newly established company called Grail and spun out from Illumina promises to develop a “liquid biopsy” test suitable for asymptomatic cancer detection and general screening. While the necessary sensitivity may be ...
Chroniques génomiques - Cancer : les trois époques de la médecine personnalisée :
(Éditions EDK, Groupe EDP Sciences, 2017)
Since the completion of the first human DNA sequence, genomic approaches have penetrated into cancer research and therapy: first through expression profiling for diagnostic, prognostic and predictive purposes, then by ...
Chroniques génomiques - Dépister les cancers asymptomatiques ?
(EDP Sciences, 2018)
A recent publication describes a sophisticated “liquid biopsy” procedure that analyses both tumoral DNA and proteins present in peripheral blood to provide sensitive detection of different types of cancer. These results ...
Chroniques génomiques : Des signatures sans valeur ?
(Éditions EDK/Groupe EDP Sciences, 2012)
Chroniques génomiques - Scores polygéniques et risque de cancer
(EDP Sciences, 2020)
Risk assessment for a cancer type with moderate heritability can be accurately performed using a relatively small number of SNPs detected by GWAS analyses to calculate a polygenic risk score (PRS) that has definite clinical ...